D.E. Shaw & Co
ONC

D.E. Shaw & Co’s BeOne Medicines Ltd ONC Stock Holding History

D.E. Shaw & Co’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$475K Sell
1,600
-800
-33% -$259K ﹤0.01% 3875
2025
Q4 		$729K Buy
+2,400
New +$786K ﹤0.01% 3733
2022
Q2 		– Sell
-10,000
Closed -$1.89M – 5854
2022
Q1 		$1.89M Buy
+10,000
New +$2.13M ﹤0.01% 3360
2019
Q1 		– Sell
-25,000
Closed -$3.51M – 3989
2018
Q4 		$3.51M Hold
25,000
– – ﹤0.01% 1747
2018
Q3 		$4.31M Buy
+25,000
New +$4.2M 0.01% 1674
2018
Q2 		– Sell
-10,000
Closed -$1.68M – 3927
2018
Q1 		$1.68M Hold
10,000
– – ﹤0.01% 2164
2017
Q4 		$977K Buy
+10,000
New +$915K ﹤0.01% 2585

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return